Ally Financial Inc. Acquires Shares of 103,000 Baxter International Inc. $BAX

Key Points

• Ally Financial acquired 103,000 Baxter International shares in the second quarter, valued at approximately $2.2 million. Institutional investors collectively own 90.19% of Baxter’s outstanding stock.
• Baxter reported quarterly EPS of $0.56, beating estimates by $0.19, while revenue rose 5.3% year over year to $2.96 billion. The company maintained fiscal 2026 EPS guidance of $1.95–$2.15.
• Analysts remain broadly cautious, with a consensus “Hold” rating and average price target of $22.45, below the stock’s recent $26.37 price. Baxter also announced a quarterly dividend of $0.01 per share, representing a 0.2% yield.

Ally Financial Inc. acquired a new stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 103,000 shares of the medical instruments supplier's stock, valued at approximately $2,196,000.

Other hedge funds also recently made changes to their positions in the company. Covestor Ltd raised its position in Baxter International by 9.5% during the fourth quarter. Covestor Ltd now owns 8,014 shares of the medical instruments supplier's stock valued at $153,000 after purchasing an additional 695 shares during the period. Bruce G. Allen Investments LLC increased its position in shares of Baxter International by 22.8% during the 4th quarter. Bruce G. Allen Investments LLC now owns 4,452 shares of the medical instruments supplier's stock valued at $85,000 after purchasing an additional 827 shares during the last quarter. Jump Financial LLC raised its holdings in Baxter International by 5.7% during the 4th quarter. Jump Financial LLC now owns 15,968 shares of the medical instruments supplier's stock valued at $305,000 after buying an additional 854 shares during the period. Nicholas Hoffman & Company LLC. lifted its position in Baxter International by 2.1% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 46,913 shares of the medical instruments supplier's stock worth $897,000 after buying an additional 943 shares during the last quarter. Finally, LRI Investments LLC lifted its position in Baxter International by 48.2% in the fourth quarter. LRI Investments LLC now owns 3,006 shares of the medical instruments supplier's stock worth $57,000 after buying an additional 978 shares during the last quarter. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Baxter International Trading Up 0.1%

Shares of NYSE:BAX opened at $26.37 on Monday. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The business's fifty day simple moving average is $23.62 and its 200-day simple moving average is $20.36. The company has a market capitalization of $13.63 billion, a PE ratio of -12.74, a P/E/G ratio of 3.99 and a beta of 0.59. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39.

Baxter International (NYSE:BAX - Get Free Report) last posted its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same quarter in the previous year, the firm earned $0.59 earnings per share. The firm's quarterly revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, equities research analysts predict that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, August 28th. Baxter International's payout ratio is -1.93%.

Analysts Set New Price Targets

Several research firms have recently issued reports on BAX. The Goldman Sachs Group raised their target price on shares of Baxter International from $19.00 to $21.00 and gave the stock a "neutral" rating in a report on Wednesday, July 15th. UBS Group increased their target price on Baxter International from $19.00 to $25.00 and gave the stock a "hold" rating in a research note on Tuesday, July 28th. Citigroup upgraded Baxter International from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $17.00 to $28.00 in a research report on Friday, July 31st. Zacks Research raised shares of Baxter International from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 11th. Finally, Barclays upped their price target on shares of Baxter International from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Friday, May 1st. Two equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Baxter International has an average rating of "Hold" and a consensus price target of $22.45.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source